rDEN2delta30-7169

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University

Conditions

DengueDengue infection DengueHealthy VolunteersHuman Challenge Trial

Early Phase 1

Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169 in Thai Healthy Volunteers

Active, not recruitingTCTR20220706004

Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDengue infection Dengue

Start: 2022-08-01Target: 5Updated: 2026-08-03

Phase 1

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

RecruitingNCT07706686

National Institute of Allergy and Infectious Diseases (NIAID)Dengue, Healthy Volunteers, Human Challenge Trial

Start: 2026-08-07End: 2029-05-03Target: 200Updated: 2026-09-10